thiazolyl blue has been researched along with Brain Vascular Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cintado-Benítez, A; Cruz-Ramírez, A; Delgado-Roche, L; Fernández-Massó, JR; Llópiz-Arzuaga, A; Marín-Prida, J; Mendoza-Marí, Y; Nazábal-Gálvez, M; Pardo-Andreu, GL; Pavón-Fuentes, N; Pentón-Arias, E; Pentón-Rol, G; Polentarutti, N; Riva, F; Santana, SP; Valenzuela-Silva, C | 1 |
1 other study(ies) available for thiazolyl blue and Brain Vascular Disorders
| Article | Year |
|---|---|
Phycocyanobilin promotes PC12 cell survival and modulates immune and inflammatory genes and oxidative stress markers in acute cerebral hypoperfusion in rats.
Topics: Animals; Biomarkers; Brain Chemistry; Cell Survival; Cerebrovascular Disorders; Coloring Agents; Cytokines; Genes, MHC Class II; Glutamic Acid; Hydrogen Peroxide; Inflammation; Male; Microarray Analysis; Oxidation-Reduction; Oxidative Stress; PC12 Cells; Phycobilins; Phycocyanin; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Spirulina; Tetrazolium Salts; Thiazoles; Vascular Endothelial Growth Factor A | 2013 |